United States Neurology Devices Market

USA Neurology Devices Market Analysis

The United States Neurology Devices Market is expected to register a CAGR of 7.9% during the forecast period.

USA Neurology Devices Market Trends

Neurostimulation Devices is Expected to Show Good Growth Over the Forecast Period

The fastest growth of the segment is due to the increasing usage of the sacral nerve stimulation devices and deep brain stimulation devices. The sacral nerve stimulation devices are mostly used for patients for whom drug therapy or other types of medications are not successful. These devices are found to be successful in treating bladder problems. Hence, with increasing incidences of overactive bladder, the sacral nerve stimulation devices segment is expected to grow during the forecast period. The deep brain stimulation devices are generally used to treat neuropsychiatric disorders and are effectively used in treating various other neurological disorders, like Parkinson's disease, essential tremor, dystonia, chronic pain, major depression, and obsessive-compulsive disorder. According to ParkinsonsDisease.net, 2019, 1 million Americans are living with PD, and approximately 60,000 Americans are diagnosed with PD each year. With the increasing neurological diseases like this, the segment is bound to grow at a higher growth rate.

USA Neurology Devices Industry Overview

The United States Neurology Devices Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players are B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, Abbott Laboratories, Johnson and Johnson, Smith & Nephew, etc.

USA Neurology Devices Market Leaders